Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for ANIK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 0.643M
March 31, 2026 8.69M
December 31, 2025 5.275M
September 30, 2025 0.00
June 30, 2025 -0.261M
March 31, 2025 3.971M
December 31, 2024 5.278M
September 30, 2024 3.969M
June 30, 2024 0.906M
March 31, 2024 -0.023M
December 31, 2023 -0.335M
September 30, 2023 0.00
June 30, 2023 4.514M
March 31, 2023 -0.007M
December 31, 2022 -0.666M
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 -0.015M
December 31, 2021 -0.114M
September 30, 2021 -0.371M
June 30, 2021 -0.643M
March 31, 2021 0.00
December 31, 2020 -1.456M
September 30, 2020 0.00
June 30, 2020 -0.209M
Date Value
March 31, 2020 0.141M
December 31, 2019 -0.571M
September 30, 2019 -21.57M
June 30, 2019 30.00M
March 31, 2019 -0.005M
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 27.63M
March 31, 2018 -0.512M
December 31, 2017 -0.004M
September 30, 2017 -0.101M
June 30, 2017 -0.168M
March 31, 2017 -0.041M
December 31, 2016 -0.019M
September 30, 2016 -0.066M
June 30, 2016 -0.254M
March 31, 2016 24.33M
December 31, 2015 0.0008M
September 30, 2015 -0.1058M
June 30, 2015 -0.0054M
March 31, 2015 -0.9636M
December 31, 2014 -0.6754M
September 30, 2014 -0.0175M
June 30, 2014 -0.294M
March 31, 2014 -1.068M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Perspective Therapeutics, Inc. -0.16M
MiMedx Group, Inc. 12.60M
ABVC BioPharma, Inc. 0.00
Enovis Corp. -0.38M
Edwards Lifesciences Corp. -0.50M